Lysophosphatidylcholine stimulates phospholipase D in human coronary endothelial cells: Role of PKC

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 271, Issue 4 40-4, 1996, Pages

  Cox, David A ^a   Cohen, Marlene L ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

atherosclerosis; calphostin C; chelerythrine; GF 109203X; inflammation

Indexed keywords

2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; CALPHOSTIN C; CHELERYTHRINE; GENISTEIN; LYSOPHOSPHATIDYLCHOLINE; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; PHOSPHOLIPID; PROTEIN KINASE C;

ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CELL CULTURE; DATA ANALYSIS; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

EID: 33750813558     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.1996.271.4.h1706     Document Type: Article

References (36)

1. Akiyama, T., J. Ishida, S. Nakgawa, H. Ogawara, W. Watanabe, N. Itoh, M. Shibuya, and Y. Fuyami. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J. Biol. Chem. 262: 5592-5595, 1987.
2. Bligh, E. G., and W. T. Dyer. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37: 911-917, 1959.
3. Bonser, R. W., N. T. Thompson, R. W. Randall, and L. G. Garland. Phospholipase D is functionally linked to superoxide generation in the human neutrophil. Biochem. J. 264: 617-620, 1989.
4. Bruns, R. F., F. D. Miller, R. L. Merriman, J. J. Howbert, W. F. Heath, E. Kobayashi, I. Takahashi, T. Tamaoki, and H. Nakano. Inhibition of protein kinase C by calphostin C is light dependent. Biochem. Biophys. Res. Commun. 176: 288-293, 1991.
5. Budworth, J., and A. Gescher. Differential inhibition of cytosolic and membrane-derived protein kinase C activity by stauro-sporine and other kinase inhibitors. FEBS Lett. 362: 139-142, 1995.
6. Chijiwa, T., A. Mishima, M. Hagiwara, M. Sano, K. Hayashi, T. Inoue, K. Naito, T. Toshioka, and H. Hidaka. Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-((p-bromocinnamyl)amino) ethyl]-5-isoquinolinesulfonamide (H-89), of PC12D pheochromocytoma cells. J. Biol. Chem. 265: 5267-5272, 1990.
7. Cox, D. A., and M. L. Cohen. Selective enhancement of 5-hydroxytryptamine (5-HT)-induced contraction of porcine coronary artery by oxidized low-density lipoprotein. J. Pharmacol. Exp. Ther. 276: 1095-1103, 1996.
8. Flavahan, N. A. Lysophosphatidylcholine modifies G protein-dependent signaling in porcine endothelial cells. Am. J. Physiol. 264 (Heart Circ. Physiol. 33): H722-H727, 1993.
9. Garcia, J. G. N., J. W. Fenton II, and V. Natajaran. Thrombin-stimulation of human endothelial cell phospholipase D activity. Regulation by phospholipase C, protein kinase C, and cyclic adenosine 3′5′-monophosphate. Blood 79: 2056-2067, 1992.
10. Gazit, A., P. Yaish, C. Gilon, and A. Levitzki. Tyrphostins I: synthesis and biological activity of protein tyrosine kinase inhibitors. J. Biol. Chem. 32: 2344-2352, 1989.
11. Herbert, J.-M., P. Savi, M.-C. Laplace, A. Dumas, and F. Dol. Chelerythrine, a selective protein kinase C inhibitor, counteracts pyrogen-induced expression of tissue factor without effect on thrombomodulin down-regulation in endothelial cells. Thromb. Res. 71: 487-493, 1993.
12. Hirata, K., N. Miki, Y. Kurodo, T. Sakoda, S. Kawashima, and M. Yokoyama. Low concentrations of oxidized low-density lipoprotein and lysophosphatidycholine upregulate constitutive nitric oxide synthase mRNA expression in bovine aortic endothelial cells. Circ. Res. 76: 958-962, 1995.
13. Inoue, N., K. Hirata, M. Yamada, Y. Hamamori, Y. Matsuda, H. Akita, and M. Yokoyama. Lysophosphatidylcholine inhibits bradykinin-induced phosphoinositide hydrolysis and calcium transients in cultured bovine aortic endothelial cells. Circ. Res. 71: 1410-1421, 1992.
14. Jones, A. W., S. D. Shukla, and B. B. Geisbuhler. Stimulation of phospholipase D activity and phosphatidic acid production by norepinephrine in rat aorta. Am. J. Physiol. 264 (Cell Physiol. 33): C609-C616, 1993.
15. Jordan, N. J., M. L. Watson, T. Yoshimura, and J. Westwick. Differential effects of protein kinase C inhibitors on chemokine production in human synovial fibroblasts. Br. J. Pharmacol. 117: 1245-1253, 1996.
16. Kugiyama, K., M. Ohgusbi, S. Sugiyama, T. Murohara, K. Fukunaga, E. Miyamoto, and Y. Yasue. Lysophosphatidylcholine inhibits surface receptor-mediated intracellular signals in endothelial cells by a pathway involving protein kinase C activation. Circ. Res. 71: 1422-1428, 1992.
17. Kume, N., M. I. Cybulsky, and M. A. Gimbrone, Jr. Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit endothelial cells. J. Clin. Invest. 90: 1138-1144, 1992.
18. Kume, N., and M. A. Gimbrone, Jr. Lysophosphatidylcholine transcriptionally induces growth factor gene expression in cultured human endothelial cells. J. Clin. Invest. 93: 907-911, 1994.
19. Lawson, D. L., J. L. Mehta, and W. W. Nichols. Coronary reperfusion in dogs inhibits endothelium-dependent relaxation: role of superoxide radicals. Free Radical Biol. Med. 8: 373-380, 1990.
20. Mattila, P., M.-L. Majuri, S. Tiisala, and R. Renkonen. Expression of six protein kinase C isotypes in endothelial cells. Life Sci. 55: 1253-1260, 1994.
21. McCord, J. M. Free radicals and inflammation: protection of synovial fluid by superoxide dismutase. Science Wash. DC 185: 529-531, 1974.
22. Natajaran, V., and J. G. N. Garcia. Agonist-induced activation of phospholipase D in bovine pulmonary artery endothelial cells: regulation by protein kinase C and calcium. J. Lab. Clin. Med. 121: 337-347, 1993.
23. Nishizuka, Y. Protein kinase C and lipid signaling for sustained cellular responses. FASEB J. 9: 484-496, 1995.
24. Ohgushi, M., K. Kugiyama, K. Fukunaga, T. Murohara, S. Sugiyama, E. Miyamoto, and H. Yasue. Protein kinase C inhibitors prevent impairment of endothelium-dependent relaxation by oxidatively-modified LDL. Arterioscler. Thromb. 13. 1525-1532, 1993.
25. Oishi, K., R. L. Raynor, P. A. Charp, and J. F. Kuo. Regulation of protein kinase C by lysophospholipids. Potential role in signal transduction. J. Biol. Chem. 263: 6865-6871, 1988.
26. Parhami, F., Z. T. Fang, B. Yang, A. M. Fogelman, and J. A. Berliner. Stimulation of Gs and inhibition of Gi protein functions by minimally oxidized LDL. Arterioscler. Thromb. Vasc. Biol. 15: 2019-2024, 1995.
27. Portman, O. W., and M. Alexander. Lysophosphatidylcholine concentrations and metabolism in aortic intima plus inner media: effect of nutritionally induced atherosclerosis. J. Lipid Res. 10: 158-165, 1969.
28. Quinn, M. T., S. Parthasarathy, L. G. Fong, and D. Steinberg. Oxidatively-modified low density lipoproteins: a potential role in recruitment and retention of monocyte/macrophage during atherogenesis. Proc. Natl. Acad. Sci. USA 84: 2995-2998, 1987.
29. Ryborg, A. K., B. Gron, and K. Kragballe. Increased lysophosphatidylcholine content in lesional psoriatic skin. Br. J. Dermatol. 134: 398-402, 1995.
30. Schmidt, M., S. M. Huwe, B. Fasselt, D. Homann, U. Rumenapp, J. Sandmann, and K. H. Jakobs. Mechanism of phospholipase D stimulation by m3 muscarinic acetylcholine receptors. Evidence for involvement of tyrosine phosphorylation. Eur. J. Biochem. 225: 667-675, 1994.
31. Sedlis, S. P., M. Hom, J. M. Sequeira, and R. Esposito. Lysophosphatidylcholine accumulation in ischemic human myocardium. J. Lab. Clin. Med. 121: 111-117, 1993.
32. Sugiyama, S., K. Kugiyama, M. Ohgushi, K. Fujimoto, and H. Yasue. Lysophosphatidylcholine in oxidized low-density lipoprotein increases endothelial susceptibility to polymorphonuclear leukocyte-induced endothelial dysfunction in porcine coronary arteries. Role of protein kinase C. Circ. Res. 74. 565-575, 1994.
33. Thompson, N. T., L. G. Garland, and R. W. Bonser. Phospholipase D: regulation and functional significance. Adv. Pharmacol. 24: 199-238, 1993.
34. Toullee, D., P. Pianetti, H. Coste, P. Bellevergue, T. Grand-Perret, M. Ajakane, V. Baudet, P. Boissin, E. Boursier, F. Loriolle, L. Duhamel, D. Charon, and J. Kirilovsky. The bisindolylmaleimide GF109203X is a potent and selective inhibitor or protein kinase C. J. Biol. Chem. 266: 15771-15781, 1991.
35. Vidaver, G. A., A. Ting, and J. W. Lee. Evidence that lysolecithin is an important causal agent of atherosclerosis. J. Theor. Biol. 115: 27-41, 1985.
36. Zembowicz, A., S. L. Jones, and K. K. Wu. Induction of cyclooxygenase-2 in human umbilical vein endothelial cells by lysophosphatidylcholine. J. Clin. Invest. 96: 1688-1692, 1995.